0001683168-24-000706.txt : 20240206
0001683168-24-000706.hdr.sgml : 20240206
20240206102739
ACCESSION NUMBER: 0001683168-24-000706
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240201
FILED AS OF DATE: 20240206
DATE AS OF CHANGE: 20240206
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Downs Christopher
CENTRAL INDEX KEY: 0001705978
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39126
FILM NUMBER: 24598669
MAIL ADDRESS:
STREET 1: 31700 RESEARCH PARK DRIVE
CITY: MADISON HEIGHTS
STATE: MI
ZIP: 48071
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CNS Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001729427
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 822318545
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2100 WEST LOOP SOUTH
STREET 2: SUITE 900
CITY: HOUSTON
STATE: TX
ZIP: 77027
BUSINESS PHONE: 1-800-946-9185
MAIL ADDRESS:
STREET 1: 2100 WEST LOOP SOUTH
STREET 2: SUITE 900
CITY: HOUSTON
STATE: TX
ZIP: 77027
4
1
ownership.xml
X0508
4
2024-02-01
0
0001729427
CNS Pharmaceuticals, Inc.
CNSP
0001705978
Downs Christopher
C/O CNS PHARMACEUTICALS, INC.
2100 WEST LOOP SOUTH, SUITE 900
HOUSTON
TX
77027
0
1
0
0
Chief Financial Officer
0
Common stock
2024-02-01
4
P
0
66666
0.30
A
103438
D
Series A Warrant to purchase common stock
0.30
2024-02-01
4
A
0
66666
A
2024-02-01
2029-02-01
Common Stock
66666
94906
D
Series B Warrant to purchase common stock
0.30
2024-02-01
4
A
0
66666
A
2024-02-01
2025-10-01
Common Stock
66666
161572
D
The common stock, Series A warrants and Series B warrants were acquired by the reporting person in a public offering conducted by the Company that was closed on February 1, 2024.
/s/ Christopher Downs
2024-02-05